Skip to content

Diagnosis of childhood Tuberculosis by tuberculin antigen test- A Randomised study

Comparison of 2TU and 1 TU purified protein derivative for Mx test to detect childhood tuberculosis-A randomised study - Mx for TB diagnosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/11/007446
Enrollment
304
Registered
2016-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Childrn aged 6 months to 12 years with clinical features suggestive of Tuberculosis

Interventions

Intervention1: PURIFIED PROTEIN DERIVATIVE ANTIGEN: .1ml of 1 TU and 2 TU PPD will be administered intradermally on right and left forearm of children aged 6 months to 12 years with features suggestiv

Sponsors

Jawaharlal Institute of Postgraduate medical education and ResearchJIPMERPondicherry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: any one of the following 1.fever and/or cough more than 2 weeks 2.Loss of weight(more than 5 % of body weight or no weight gain over 3 months ) 3.H/o contact with infectious TB case 4.Progressive enlargement of lymphnode for more than 2weeks. 5.Fever more than 7 days with irritability/drowsiness/vomiting/seizures/Focal neurologicaldeficits

Exclusion criteria

Exclusion criteria: 1.inherited or acquired immunodeficiency 2.Children immunosuppressed by drugs or disease 3.Children with h/o recent measles infection 4.Children recently vaccinated with live viral vaccine

Design outcomes

Primary

MeasureTime frame
Horizontal diameter of induration(in mm) with 1 TU and 2 TU PPD 48 hours after mantoux testTimepoint: 48 hours after the mantoux test(intradermal)

Secondary

MeasureTime frame
Sensitivity and specificity of Mantoux test with 1 TU and 2 TU PPD in detection of Childhood tuberculosis.Timepoint: 7 days

Countries

India

Contacts

Public ContactDrNithinSN

JIPMER

drnbiswal@yahoo.com9442528402

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026